Therapeutic Potential of Fungal Polysaccharides in Gut Microbiota Regulation: Implications for Diabetes, Neurodegeneration, and Oncology

Overview

Journal J Fungi (Basel)

Date 2024 Jun 26

PMID 38921380

Authors

Alexandru Stefan Barcan

Rares Andrei Barcan

Emanuel Vamanu

Affiliations

Soon will be listed here.

Abstract

This review evaluates the therapeutic effects of polysaccharides derived from mushroom species that have medicinal and edible properties. The fungal polysaccharides were recently studied, focusing on their modulation of the gut microbiota and their impact on various diseases. The study covers both clinical and preclinical studies, detailing the results and highlighting the significant influence of these polysaccharides on gut microbiota modulation. It discusses the potential health benefits derived from incorporating these polysaccharides into the diet for managing chronic diseases such as diabetes, neurodegenerative disorders, and cancer. Furthermore, the review emphasizes the interaction between fungal polysaccharides and the gut microbiota, underscoring their role in modulating the gut microbial community. It presents a systematic analysis of the findings, demonstrating the substantial impact of fungal polysaccharides on gut microbiota composition and function, which may contribute to their therapeutic effects in various chronic conditions. We conclude that the modulation of the gut microbiota by these polysaccharides may play a crucial role in mediating their therapeutic effects, offering a promising avenue for further research and potential applications in disease prevention and treatment.

Citing Articles

The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review.

Nakhal M, Yassin L, Alyaqoubi R, Saeed S, Alderei A, Alhammadi A Life (Basel). 2024; 14(10).

PMID: 39459534 PMC: 11508655. DOI: 10.3390/life14101234.

Chemical Composition, Antioxidant and Anti-Inflammatory Activity of Shiitake Mushrooms ().

Xu X, Yu C, Liu Z, Cui X, Guo X, Wang H J Fungi (Basel). 2024; 10(8).

PMID: 39194878 PMC: 11355609. DOI: 10.3390/jof10080552.

References

Zhang D, Xiang M, Jiang Y, Wu F, Chen H, Sun M . The Protective Effect of Polysaccharide SAFP from on Water Immersion and Restraint Stress-Induced Gastric Ulcer and Modulatory Effects on Gut Microbiota Dysbiosis. Foods. 2022; 11(11). PMC: 9180856. DOI: 10.3390/foods11111567. View

Zhang W, Hu B, Liu C, Hua H, Guo Y, Cheng Y . Comprehensive analysis of Sparassis crispa polysaccharide characteristics during the in vitro digestion and fermentation model. Food Res Int. 2022; 154:111005. DOI: 10.1016/j.foodres.2022.111005. View

Wang Y, Chen R, Yang Z, Wen Q, Cao X, Zhao N . Protective Effects of Polysaccharides in Neurodegenerative Diseases. Front Aging Neurosci. 2022; 14:917629. PMC: 9289469. DOI: 10.3389/fnagi.2022.917629. View

Wang Q, Luo Y, Chaudhuri K, Reynolds R, Tan E, Pettersson S . The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options. Brain. 2021; 144(9):2571-2593. DOI: 10.1093/brain/awab156. View

Golisch B, Lei Z, Tamura K, Brumer H . Configured for the Human Gut Microbiota: Molecular Mechanisms of Dietary β-Glucan Utilization. ACS Chem Biol. 2021; 16(11):2087-2102. DOI: 10.1021/acschembio.1c00563. View

Yang M, Hu D, Cui Z, Li H, Man C, Jiang Y . Lipid-Lowering Effects of Polysaccharide In Vivo and In Vitro. Foods. 2021; 10(12). PMC: 8700920. DOI: 10.3390/foods10123085. View

Zyoud S, Al-Jabi S, Amer R, Shakhshir M, Shahwan M, Jairoun A . Global research trends on the links between the gut microbiome and cancer: a visualization analysis. J Transl Med. 2022; 20(1):83. PMC: 8832721. DOI: 10.1186/s12967-022-03293-y. View

Nishiyama K, Yokoi T, Sugiyama M, Osawa R, Mukai T, Okada N . Roles of the Cell Surface Architecture of and in the Gut Colonization. Front Microbiol. 2021; 12:754819. PMC: 8551831. DOI: 10.3389/fmicb.2021.754819. View

Yildirim S, Nalbantoglu O, Bayraktar A, Ercan F, Gundogdu A, Velioglu H . Stratification of the Gut Microbiota Composition Landscape across the Alzheimer's Disease Continuum in a Turkish Cohort. mSystems. 2022; 7(1):e0000422. PMC: 8823292. DOI: 10.1128/msystems.00004-22. View

10.

Katoh T, Ojima M, Sakanaka M, Ashida H, Gotoh A, Katayama T . Enzymatic Adaptation of to Host Glycans, Viewed from Glycoside Hydrolyases and Carbohydrate-Binding Modules. Microorganisms. 2020; 8(4). PMC: 7232152. DOI: 10.3390/microorganisms8040481. View

11.

Zhang Y, Zhang L, Zheng S, Li M, Xu C, Jia D . promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis. Gut Microbes. 2022; 14(1):2038852. PMC: 8890384. DOI: 10.1080/19490976.2022.2038852. View

12.

Li Y, Ouyang Q, Li X, Alolgal R, Fan Y, Sun Y . The Role of in Regulating Hyperlipidemia. Am J Chin Med. 2023; 51(4):953-978. DOI: 10.1142/S0192415X23500441. View

13.

Frommhagen M, Sforza S, Westphal A, Visser J, Hinz S, Koetsier M . Discovery of the combined oxidative cleavage of plant xylan and cellulose by a new fungal polysaccharide monooxygenase. Biotechnol Biofuels. 2015; 8:101. PMC: 4504452. DOI: 10.1186/s13068-015-0284-1. View

14.

Kim C . Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids. Cell Mol Immunol. 2021; 18(5):1161-1171. PMC: 8093302. DOI: 10.1038/s41423-020-00625-0. View

15.

Su L, Xin C, Yang J, Dong L, Mei H, Dai X . A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus. Int J Biol Macromol. 2022; 214:312-323. DOI: 10.1016/j.ijbiomac.2022.06.071. View

16.

Doocey C, Finn K, Murphy C, Guinane C . The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol. 2022; 22(1):53. PMC: 8840051. DOI: 10.1186/s12866-022-02465-6. View

17.

Francesco Rodrigues de Oliveira B, Freitas-Silva J, Canellas A, Costa W, Laport M . Time for a Change! A Spotlight on Many Neglected Facets of Sponge Microbial Biotechnology. Curr Pharm Biotechnol. 2022; 24(4):471-485. DOI: 10.2174/1389201023666220516103715. View

18.

Bakhrushina E, Mikhel I, Kondratieva V, Demina N, Grebennikova T, Krasnyuk Jr I . Main Aspects of Pharmaceutical Development of Immunobiological Drugs for Intranasal Administration. Curr Pharm Biotechnol. 2023; 25(11):1394-1405. DOI: 10.2174/0113892010260017231002075152. View

19.

Huang Z, Huang Q, Chen K, Huang Z, Liu Y, Jia R . fruit body polysaccharide alleviates hyperglycemia and hyperlipidemia modulating intestinal microflora in type 2 diabetic mice. Front Nutr. 2022; 9:1013466. PMC: 9632624. DOI: 10.3389/fnut.2022.1013466. View

20.

Xu N, Zhou Y, Lu X, Chang Y . Auricularia auricula-judae (Bull.) polysaccharides improve type 2 diabetes in HFD/STZ-induced mice by regulating the AKT/AMPK signaling pathways and the gut microbiota. J Food Sci. 2021; 86(12):5479-5494. DOI: 10.1111/1750-3841.15963. View